SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-22-000163
Filing Date
2022-11-10
Accepted
2022-11-10 16:10:26
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20221110.htm   iXBRL 8-K 32526
2 EX-99.1 a20220930ex991pressrelease.htm EX-99.1 78182
6 frtx_logoxcolora.jpg GRAPHIC 64155
  Complete submission text file 0000819050-22-000163.txt   344778

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20221110.xsd EX-101.SCH 1891
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20221110_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20221110_pre.xml EX-101.PRE 13042
8 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20221110_htm.xml XML 11275
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 221377232
SIC: 2836 Biological Products, (No Diagnostic Substances)